Abbvie M16 553: An Open-Label, Phase 1 Study of SC-004 as Monotherapy and in Combination with ABBV-181 in Subjects with Epithelial Ovarian, Including Fallopian Tube and Primary Peritoneal, and Endometrial Cancers

October 26, 2018
https://clinicaltrials.gov/ct2/show/NCT03138408
Cancer - Gynecologic/ Ovarian
Principal Investigator: Ding Wang, MD
Epithelial ovarian, fallopian tube, primary peritoneal, endometrial cancers, ovarian, cancer
Accepting Participants